CML is one of the few malignant diseases triggered by a single oncogene, bcr–abl, encoding an abnormal protein with constitutive tyrosine kinase activity, responsible for proliferative and anti-apoptotic signals. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.